InvestorsHub Logo
Followers 248
Posts 13716
Boards Moderated 0
Alias Born 05/19/2015

Re: takuacheofwallstreet post# 102345

Thursday, 01/06/2022 6:40:09 PM

Thursday, January 06, 2022 6:40:09 PM

Post# of 118421
From ONPH 12-9-21 year end Review
During this past year Oncology Pharma has also signed license agreements with Regen BioPharma, Inc. for its small molecule and for the mRNA technology to address colon cancer and pancreatic cancer. It is the Company's intent that in the beginning of next year it will further engage with our team to advance these licenses along the same path as we have with the nanoemulsion of dactinomycin.